Riskpilot← Back to searchSign inGet full accessPharma N&E AB
ABActiveOrg 5593938763Economic activity was not specified by tax authority · NACE 0000Est. 20220 employees
Revenue 2024
SEK 0
EBITDA margin
—
-31% vs 2023
Equity ratio
93.6%
Financial strength
Net profit 2024
SEK -603K
-111% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -28K | -31% |
| Net profit | SEK -603K | -111% |
| Total assets | SEK 358K | -46% |
| Equity | SEK 335K | -48% |
| Employees | 0 | — |
Legal name
Pharma N&E AB
Org number
5593938763
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
25 augusti 2022
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget har som verksamhet att förvalta aktier i bolag som bedriver apoteksverksamhet samt att bedriva konsultverksamhet
Address
Email
farkas.eva.reka@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 0 | 0 |
| Staff expenses | — | — |
| EBITDA | −22 | −28 |
| Depreciation & amort. | — | — |
| EBIT | −22 | −28 |
| Net financials | −265 | −575 |
| Profit before tax | — | — |
| Tax | — | — |
| Net profit | −287 | −603 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 660 | 358 |
| Equity | 638 | 335 |
| Long-term debt | — | — |
| Short-term debt | 22 | 23 |
| Total debt | 22 | 23 |
EBITDA margin
-2843400.0%
This company
15.8%
Market median
-17996303% vs market
20232024
Equity ratio
93.6%
This company
38.2%
Market median
+145% vs market
20232024
Return on equity
-180.2%
This company
18.4%
Market median
-1079% vs market
20232024
Net profit margin
-60343400.0%
This company
8.1%
Market median
-744980347% vs market
20232024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20232024
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JK Chief Auditor | Chief Auditor | 2025 |
ÉR Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Pharma N&E AB 
Aponeja ABBoard members of Pharma N&E AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Karl Lahiru Nilsson | Chief Auditor | 0 companies |
| Éva Réka Accaoui | Chief Executive Officer | 0 companies |
| Goran Jovanovic | Deputy Board Member | 0 companies |
| Raymond Maté Accaoui | Deputy Board Member | 0 companies |
| Natasa Jovanovic | Chairman | 0 companies |